GlassScriptPhysician profile
Kevin Miller
NPI 1649821398
$693.09
in general payments reported to CMS, 2019-2025
12 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.95 · 2022: $148 · 2023: $248 · 2024: $83.04 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $153.95 | 2023-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $115.99 | 2022-2023 | Fanapt, Hetlioz |
| Otsuka America Pharmaceutical, INC. | $111.57 | 2022-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Alkermes, INC. | $101.23 | 2023 | Lybalvi, Aristada |
| Indivior INC. | $61.60 | 2022-2024 | Perseris |
| Teva Pharmaceuticals USA, INC. | $33.24 | 2025 | Uzedy |
| Takeda Pharmaceuticals U.S.A., INC. | $25.01 | 2021 | |
| Janssen Pharmaceuticals, INC | $21.51 | 2023 | Invega Sustenna |
| Sunovion Pharmaceuticals INC. | $20.64 | 2022 | |
| Atricure, INC. | $18.58 | 2024 | |
| Sage Therapeutics, LLC | $15.83 | 2024 | |
| Abbvie INC. | $13.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.